Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 3825-3830, July 1, 2007. doi: 10.1158/1078-0432.CCR-07-0358
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elliott, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, B.

Imaging, Diagnosis, Prognosis

Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma

Bruce Elliott1,2, Richard A. Scolyer3, Stefan Suciu5, Serge Lebecque6, Donata Rimoldi7, Oliver Gugerli8, Elena Musat5, Raghwa N. Sharma3,4, Danielle Lienard8, Ulrich Keilholz9, Alessandro Testori10, Alexander Eggermont11, Rona MacKie12, Caroline Robert13, Martin Cook1, John F. Thompson3, Eric Angevin13, Alain Spatz13 on behalf of the European Organization for Research and Treatment of Cancer Melanoma Group

Authors' Affiliations: 1 Royal Surrey County Hospital Guildford, Guildford, United Kingdom; 2 St George's University of London, London, United Kingdom; 3 Royal Prince Alfred Hospital, and 4 Wesmead Hospital, Sydney, Australia; 5 European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium; 6 Hospices Civils de Lyon, Université Lyon 1, Lyon, France; 7 Ludwig Institute for Cancer Research, Lausanne Branch, and 8 Lausanne University Hospital, Lausanne, Switzerland; 9 Charite Hospital, Berlin, Germany; 10 European Institute of Oncology, Milan, Italy; 11 Erasmus Medical Center, Rotterdam, the Netherlands; 12 Glasgow University Hospital, Glasgow, United Kingdom; and 13 Gustave-Roussy Institute, Villejuif, France

Requests for reprints: Alain Spatz, Department of BioPathology, Gustave Roussy Institute, 94805 Villejuif, France. Phone: 33-142-114-462; Fax: 33-142-115-263; E-mail: spatz{at}igr.fr.

Purpose: In a previous immunohistochemical study of dendritic cells (DC) in sentinel lymph nodes (SLN) draining regressing melanomas, we found that the accumulation of mature DC-LAMP+ DCs in SLNs was associated with local expansion of antigen-specific memory effector CTLs and the absence of metastasis in downstream lymph nodes. The aim of this study was to investigate the prognostic importance of the maximal density of mature DCs in SLNs.

Experimental Design: A total of 458 consecutive patients with micrometastatic melanoma within SLNs were eligible for analysis. The maximal density of mature DC-LAMP+ DCs was evaluated by three independent observers and categorized into three classes (<100, 100 to <200, and ≥200/mm2).

Results: There was excellent interobserver reproducibility for maximum density of mature DC-LAMP+ DC scores ({kappa} score = 0.82). There were differences in the maximal density scores and staining intensity according to the treating melanoma center (P < 0.001). The higher the mature DC density in the SLN is, the longer is the duration of survival [P = 0.047; hazard ratio, 0.70; 95% confidence interval, 0.50-1.00]. Adjusted by thickness and ulceration, the prognostic importance of DC density was lower (P = 0.36).

Conclusion: This study is the first to report the prognostic value of DC-LAMP+ DC counts in SLNs containing metastatic melanoma. Patients with a high density of mature DCs (≥200/mm2) have the lowest risk of death. It also provides evidence that a lack of maturation in the SLNs is important in biological facilitation of melanoma progression.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M G Cook and S Di Palma
Pathology of sentinel lymph nodes for melanoma
J. Clin. Pathol., August 1, 2008; 61(8): 897 - 902.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.